Changes in metabolic risk factors over 10 years and their associations with late-life cognitive performance

The Multi-Ethnic Study of Atherosclerosis

Timothy M. Hughes, Suzanne Craft, Laura D. Baker, Mark A. Espeland, Stephen R. Rapp, Kaycee M. Sink, Alain G. Bertoni, Gregory L. Burke, Rebecca F Gottesman, Erin Donnelly Michos, José A. Luchsinger, Annette L. Fitzpatrick, Kathleen M. Hayden

Research output: Contribution to journalArticle

Abstract

Background We examined whether changes in metabolic factors over 10 years were associated with cognitive performance. Methods Participants from the Multi-Ethnic Study of Atherosclerosis were followed since baseline (2000–2002) with five clinical examinations. At exam 5 (2010–2012), they received a short cognitive battery (Cognitive Abilities Screening Instrument [CASI], Digit Symbol Coding [DSC], and Digit Span [DS]). We examined associations between baseline metabolic factors and their changes over time before cognitive testing. Results Among 4392 participants, baseline metabolic disorders (fasting glucose, systolic and diastolic blood pressures) were significantly associated with poorer CASI, DSC, and DS scores measured 10 years later. Increases in blood pressure were associated with lower cognitive performance. Results did not differ by race/ethnicity and were stronger among those without the APOE ε4 allele. Conclusions Cognitive performance was associated with antecedent abnormalities in glucose metabolism and blood pressure increases. Findings appeared stronger among APOE ε4-negative participants.

Original languageEnglish (US)
Pages (from-to)18-25
Number of pages8
JournalAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
Volume8
DOIs
StatePublished - 2017

Fingerprint

Atherosclerosis
Blood Pressure
Aptitude
Glucose Metabolism Disorders
Fasting
Alleles
Glucose

Keywords

  • Brain
  • Cognitive function
  • Metabolic disorders
  • Metabolism

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health

Cite this

Changes in metabolic risk factors over 10 years and their associations with late-life cognitive performance : The Multi-Ethnic Study of Atherosclerosis. / Hughes, Timothy M.; Craft, Suzanne; Baker, Laura D.; Espeland, Mark A.; Rapp, Stephen R.; Sink, Kaycee M.; Bertoni, Alain G.; Burke, Gregory L.; Gottesman, Rebecca F; Michos, Erin Donnelly; Luchsinger, José A.; Fitzpatrick, Annette L.; Hayden, Kathleen M.

In: Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 8, 2017, p. 18-25.

Research output: Contribution to journalArticle

Hughes, Timothy M. ; Craft, Suzanne ; Baker, Laura D. ; Espeland, Mark A. ; Rapp, Stephen R. ; Sink, Kaycee M. ; Bertoni, Alain G. ; Burke, Gregory L. ; Gottesman, Rebecca F ; Michos, Erin Donnelly ; Luchsinger, José A. ; Fitzpatrick, Annette L. ; Hayden, Kathleen M. / Changes in metabolic risk factors over 10 years and their associations with late-life cognitive performance : The Multi-Ethnic Study of Atherosclerosis. In: Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 2017 ; Vol. 8. pp. 18-25.
@article{f992b85b05d64b71996c829240242e09,
title = "Changes in metabolic risk factors over 10 years and their associations with late-life cognitive performance: The Multi-Ethnic Study of Atherosclerosis",
abstract = "Background We examined whether changes in metabolic factors over 10 years were associated with cognitive performance. Methods Participants from the Multi-Ethnic Study of Atherosclerosis were followed since baseline (2000–2002) with five clinical examinations. At exam 5 (2010–2012), they received a short cognitive battery (Cognitive Abilities Screening Instrument [CASI], Digit Symbol Coding [DSC], and Digit Span [DS]). We examined associations between baseline metabolic factors and their changes over time before cognitive testing. Results Among 4392 participants, baseline metabolic disorders (fasting glucose, systolic and diastolic blood pressures) were significantly associated with poorer CASI, DSC, and DS scores measured 10 years later. Increases in blood pressure were associated with lower cognitive performance. Results did not differ by race/ethnicity and were stronger among those without the APOE ε4 allele. Conclusions Cognitive performance was associated with antecedent abnormalities in glucose metabolism and blood pressure increases. Findings appeared stronger among APOE ε4-negative participants.",
keywords = "Brain, Cognitive function, Metabolic disorders, Metabolism",
author = "Hughes, {Timothy M.} and Suzanne Craft and Baker, {Laura D.} and Espeland, {Mark A.} and Rapp, {Stephen R.} and Sink, {Kaycee M.} and Bertoni, {Alain G.} and Burke, {Gregory L.} and Gottesman, {Rebecca F} and Michos, {Erin Donnelly} and Luchsinger, {Jos{\'e} A.} and Fitzpatrick, {Annette L.} and Hayden, {Kathleen M.}",
year = "2017",
doi = "10.1016/j.dadm.2017.03.003",
language = "English (US)",
volume = "8",
pages = "18--25",
journal = "Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring",
issn = "2352-8729",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Changes in metabolic risk factors over 10 years and their associations with late-life cognitive performance

T2 - The Multi-Ethnic Study of Atherosclerosis

AU - Hughes, Timothy M.

AU - Craft, Suzanne

AU - Baker, Laura D.

AU - Espeland, Mark A.

AU - Rapp, Stephen R.

AU - Sink, Kaycee M.

AU - Bertoni, Alain G.

AU - Burke, Gregory L.

AU - Gottesman, Rebecca F

AU - Michos, Erin Donnelly

AU - Luchsinger, José A.

AU - Fitzpatrick, Annette L.

AU - Hayden, Kathleen M.

PY - 2017

Y1 - 2017

N2 - Background We examined whether changes in metabolic factors over 10 years were associated with cognitive performance. Methods Participants from the Multi-Ethnic Study of Atherosclerosis were followed since baseline (2000–2002) with five clinical examinations. At exam 5 (2010–2012), they received a short cognitive battery (Cognitive Abilities Screening Instrument [CASI], Digit Symbol Coding [DSC], and Digit Span [DS]). We examined associations between baseline metabolic factors and their changes over time before cognitive testing. Results Among 4392 participants, baseline metabolic disorders (fasting glucose, systolic and diastolic blood pressures) were significantly associated with poorer CASI, DSC, and DS scores measured 10 years later. Increases in blood pressure were associated with lower cognitive performance. Results did not differ by race/ethnicity and were stronger among those without the APOE ε4 allele. Conclusions Cognitive performance was associated with antecedent abnormalities in glucose metabolism and blood pressure increases. Findings appeared stronger among APOE ε4-negative participants.

AB - Background We examined whether changes in metabolic factors over 10 years were associated with cognitive performance. Methods Participants from the Multi-Ethnic Study of Atherosclerosis were followed since baseline (2000–2002) with five clinical examinations. At exam 5 (2010–2012), they received a short cognitive battery (Cognitive Abilities Screening Instrument [CASI], Digit Symbol Coding [DSC], and Digit Span [DS]). We examined associations between baseline metabolic factors and their changes over time before cognitive testing. Results Among 4392 participants, baseline metabolic disorders (fasting glucose, systolic and diastolic blood pressures) were significantly associated with poorer CASI, DSC, and DS scores measured 10 years later. Increases in blood pressure were associated with lower cognitive performance. Results did not differ by race/ethnicity and were stronger among those without the APOE ε4 allele. Conclusions Cognitive performance was associated with antecedent abnormalities in glucose metabolism and blood pressure increases. Findings appeared stronger among APOE ε4-negative participants.

KW - Brain

KW - Cognitive function

KW - Metabolic disorders

KW - Metabolism

UR - http://www.scopus.com/inward/record.url?scp=85017310199&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017310199&partnerID=8YFLogxK

U2 - 10.1016/j.dadm.2017.03.003

DO - 10.1016/j.dadm.2017.03.003

M3 - Article

VL - 8

SP - 18

EP - 25

JO - Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring

JF - Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring

SN - 2352-8729

ER -